Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APVO | AMGN | GILD | CELG | VRTX |
| Company | Aptevo Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1200 | 300.12 | 65.57 | 108.01 | 413.33 |
| High | 1.1500 | 307.57 | 65.61 | 108.59 | 425.65 |
| Low | 1.0100 | 298.89 | 64.76 | 107.27 | 412.12 |
| Last | 1.0250 | 307.31 | 64.92 | 108.24 | 418.82 |
| Change | -0.1350 | +7.01 | -0.54 | +0.11 | +8.58 |
| % Change | -11.64% | +2.33% | -0.82% | +0.10% | +2.09% |
| Volume | 363,400 | 2,859,000 | 5,122,300 | 191,230,496 | 1,651,100 |
| 20-Day Average Volume | 2,285,435 | 2,869,675 | 7,462,820 | 16,188,930 | 1,133,755 |
| Previous Close | 1.1600 | 300.30 | 65.46 | 108.13 | 410.24 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8457 | 277.32 | 66.30 | 108.17 | 399.69 |
| 20-Day Raw Stochastic | 50.00% | 75.31% | 12.57% | 63.25% | 80.28% |
| 20-Day Relative Strength | 33.45% | 65.94% | 32.77% | 64.69% | 59.98% |
| Weighted Alpha | -91.10 | +32.33 | -21.04 | +46.30 | +21.35 |
| Today's Opinion | 88% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 40% Buy | 100% Sell | 100% Buy | 32% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.77% since 05/01/24 | +10.79% since 05/01/24 | -0.90% since 05/01/24 | -1.97% since 11/13/19 | +4.15% since 05/01/24 |
| Low | 0.9611 on 05/03/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 394.03 on 05/07/24 |
| High | 1.3800 on 05/02/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -72.45% since 04/08/24 | +14.16% since 04/08/24 | -6.48% since 04/08/24 | +5.14% since 10/18/19 | +3.61% since 04/08/24 |
| Low | 0.6700 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 3.7887 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -84.15% since 02/08/24 | +4.23% since 02/08/24 | -12.03% since 02/08/24 | +13.63% since 08/20/19 | -1.00% since 02/08/24 |
| Low | 0.6700 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 10.8000 on 03/07/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -90.25% since 11/08/23 | +12.46% since 11/08/23 | -16.66% since 11/08/23 | +14.14% since 05/20/19 | +11.10% since 11/08/23 |
| Low | 0.6700 on 04/25/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 10.8988 on 11/09/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 496 | 161,091,424 | 81,502,736 | 77,035,920 | 106,030,224 |
| Shares Outstanding, K | 428 | 536,435 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -17,410,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -5,900,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 5.13 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -22.03 on 11/14/23 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 16.26 | 10.99 | 26.73 |